{"id":"W2762812042","doi":"10.1093/annonc/mdx362.001","title":"Neratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+ breast cancer (BC): 5-year analysis of the phase III ExteNET trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Neratinib; Medicine; Trastuzumab; Oncology; Adjuvant; Internal medicine; Breast cancer; Stage (stratigraphy); Adjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004400888,0.001051449,0.002618666,0.0002980386,0.0002518705,0.001342029,0.0007693293,0.0009499327,0.001800106],"category_scores_gemma":[0.002659634,0.000289739,0.002665712,0.000555901,0.0006780328,0.001889319,0.0005742972,0.002763915,0.0003985205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000828312,"about_ca_system_score_gemma":0.0007783381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007390695,"about_ca_topic_score_gemma":0.002011953,"domain_scores_codex":[0.9989212,0.0005765135,0.00007327999,0.0001768887,0.00008463449,0.0001675691],"domain_scores_gemma":[0.9986717,0.0004017896,0.000363585,0.0001566051,0.0000706042,0.0003357462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8802243,0.004930316,0.016028,0.001070341,0.006457545,0.0001809264,0.0001330122,0.00597256,0.00402107,0.0003637326,0.003125626,0.07749259],"study_design_scores_gemma":[0.6326892,0.2248293,0.1088037,0.0003031612,0.01164386,0.0009115968,0.00030872,0.007269686,0.003113732,0.002067138,0.007904117,0.0001556445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887403,0.007393533,0.0004051832,0.0005137305,0.0001660246,0.0002338374,0.001248187,0.0000438657,0.001255438],"genre_scores_gemma":[0.9923522,0.002905592,0.0003692535,0.0005078306,0.0001297597,0.0001924161,0.002166198,0.00002211459,0.001354651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004400888,"threshold_uncertainty_score":0.02327442,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1519478025427769,"score_gpt":0.5029018058917327,"score_spread":0.3509540033489558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}